State Street Corp Dare Bioscience, Inc. Transaction History

State Street Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.28 - $0.61 $9,660 - $21,045	34,500 Added 13.93%	282,210 $95,000
Q1 2023 May 15, 2023	BUY	$0.87 - $1.36 $18,792 - $29,376	21,600 Added 9.55%	247,710 $257,000
Q3 2022 Nov 15, 2022	BUY	$1.04 - $12.48 $3,744 - $44,928	3,600 Added 1.62%	226,110 $226,000
Q2 2022 Aug 15, 2022	BUY	$0.94 - $1.76 $41,078 - $76,912	43,700 Added 24.44%	222,510 $274,000
Q1 2022 May 16, 2022	BUY	$1.42 - $2.09 $24,821 - $36,533	17,480 Added 10.83%	178,810 $266,000
Q3 2021 Nov 15, 2021	BUY	$1.42 - $2.0 $140,154 - $197,400	98,700 Added 157.59%	161,330 $269,000
Q2 2021 Aug 16, 2021	BUY	$1.21 - $1.89 $75,782 - $118,370	62,630 New	62,630 $118,000

267K

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $270M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.